Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05RTV
|
|||
Former ID |
DIB005436
|
|||
Drug Name |
Superoxide dismutase
|
|||
Synonyms |
Orgotein; HSOD, Yeda; Manganese SOD, Boehringer Ingelheim; NK-341; Orgotein, Yeda; SOD, Yeda; Superoxide dismutase, Boehringer Ingelheim; Superoxide dismutase, Nippon; Superoxide dismutase, Yeda; HSOD, Bio-Technology General; Orgotein, Bio-Technology General; SOD, Bio-Technology General; Superoxide dismutase, Bio-Technology
Click to Show/Hide
|
|||
Indication | Myocardial infarction [ICD-11: BA41-BA43; ICD-9: 410] | Phase 2 | [1] | |
Company |
Weizmann Institute of Science; Nippon Kayaku Co Ltd; Boehringer Ingelheim Corp
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Superoxide dismutase Cu-Zn (SOD Cu-Zn) | Target Info | Modulator | [2] |
BioCyc | Reactive oxygen species degradation | |||
KEGG Pathway | Peroxisome | |||
Amyotrophic lateral sclerosis (ALS) | ||||
Huntington's disease | ||||
Prion diseases | ||||
NetPath Pathway | TCR Signaling Pathway | |||
Pathwhiz Pathway | Degradation of Superoxides | |||
Pathway Interaction Database | Validated nuclear estrogen receptor alpha network | |||
FOXA1 transcription factor network | ||||
Reactome | Platelet degranulation | |||
Detoxification of Reactive Oxygen Species | ||||
WikiPathways | Oxidative Stress | |||
Copper homeostasis | ||||
Detoxification of Reactive Oxygen Species | ||||
Nifedipine Activity | ||||
Amyotrophic lateral sclerosis (ALS) | ||||
Dopamine metabolism | ||||
AGE/RAGE pathway | ||||
Folate Metabolism | ||||
Vitamin B12 Metabolism | ||||
Selenium Micronutrient Network |
References | Top | |||
---|---|---|---|---|
REF 1 | Phase II trial of copper zinc superoxide dismutase (CuZn SOD) in the treatment of Crohn's disease. Free Radic Res Commun. 1991;12-13 Pt 2:563-9. | |||
REF 2 | Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant.Artif Cells Blood Substit Immobil Biotechnol.2011 Jun;39(3):127-36. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.